BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
SLC12A1
,
Coagulation
,
Inflammatory disorder
,
Heart
,
Holistic medicine
,
Vitamin E
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Nilotinib
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
TNFAIP3
TXNIP
CCL20
CXCL8
CPVL
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
cytosol
organic cyclic compound binding
heterocyclic compound binding
nucleoplasm
cellular aromatic compound metabolic process
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Lung cancer cells + dasatinib, imatinib, nilotinib or PD0325901
Imatinib and Nilotinib treatment on Philadelphia chromosome-positive CML
Embryonic fibroblasts of mice treated with BCR-ABL inhibitor AMN107 and IFN-alpha or IFN-gamma
Osteosarcoma U-2 OS cells treated with 6 different small molecules
L1000 CMAP - Neural progenitor NPC cells treated with small molecule perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for Nilotinib
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Nilotinib in the Treatment of Systemic Sclerosis
Nilotinib in Huntington's Disease
Nilotinib Plus Dabrafenib/Trametinib in Metastatic Melanoma
Nilotinib Plus Pegylated Interferon-α2b in CML
Nilotinib in Parkinson's Disease
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ